Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Multikine enters Canadian phase I/II trial

July 12, 1996

Antitumor vaccines described by University of Pennsylvania

July 5, 1996

Human Genome Sciences reports discovery of TNF-gamma

July 5, 1996

Virulizin undergoes phase I/II in pancreatic cancer

June 28, 1996

Multikine covered under Japanese patent

June 21, 1996

Actimmune metastatic renal cell carcinoma development terminated

June 14, 1996

E. Merck describes immunoconjugates

June 7, 1996

MuIGIF with interferon gamma production-stimulating properties identified

May 31, 1996

Results of MAb-B1 phase I/II trial announced

May 31, 1996

IMMU-14 demonstrates evidence of activity

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...